Front Desk: 469-391-0070
Fulvestrant Injection: Comprehensive Breast Cancer Treatment Guide
Summary or Key Points
Fulvestrant is a prescription medication used to treat certain types of breast cancer, including hormone receptor-positive and metastatic breast cancer. It works by blocking estrogen receptors, which helps slow or stop the growth of cancer cells. Fulvestrant is typically administered as an injection by a healthcare professional. Always consult your doctor before starting or adjusting any medication. Our telemedicine providers are available to assist with your treatment.
Names of Medication
US Brand Name: Faslodex
Generic Name: Fulvestrant
The generic name refers to the drug’s chemical composition, while the brand name is assigned by the manufacturer. In this article, the generic name is listed in parentheses.
Pharmacologic Category
Estrogen Receptor Antagonist
Selective Estrogen Receptor Degrader (SERD)
Fulvestrant Dosage
Fulvestrant is prescribed to treat various types of breast cancer in adults. The dosing schedule may vary depending on the specific condition being treated. Always follow your doctor’s instructions and consult them before making any changes to your dosage. Our telemedicine providers are available to help guide you through your treatment plan.
Breast Cancer (Hormone Receptor-Positive, Metastatic, or Advanced)
Initial Dose: 500 mg administered as two 250 mg intramuscular injections on days 1, 15, and 29.
Maintenance Dose: 500 mg every 28 days.
Estrogen Receptor-Positive Breast Cancer
Initial Dose: 500 mg on days 1, 15, and 29.
Maintenance Dose: 500 mg every 28 days.
Locally Advanced or Recurrent Breast Cancer
Initial Dose: 500 mg on days 1, 15, and 29.
Maintenance Dose: 500 mg every 28 days.
Triple-Negative Breast Cancer
Initial Dose: 500 mg on days 1, 15, and 29.
Maintenance Dose: 500 mg every 28 days.
Invasive or Non-Invasive Breast Cancer
Initial Dose: 500 mg on days 1, 15, and 29.
Maintenance Dose: 500 mg every 28 days.
Always consult your healthcare provider before adjusting your dose. If you have any questions or concerns, our telemedicine providers are available to assist you.
Dosage Forms and Strengths
Injection: 250 mg/5 mL solution in a prefilled syringe
Fulvestrant Administration Guidelines
Fulvestrant is administered as an intramuscular injection, typically by a healthcare professional. It is injected into the gluteal muscle (buttocks), usually at two separate sites. Follow your healthcare provider’s instructions closely and attend all scheduled appointments. If you miss a dose, contact your provider as soon as possible to reschedule.
Contraindications for Fulvestrant
A contraindication is a specific condition where a treatment or medication should not be used because it may be harmful. If you have any of the following conditions, Fulvestrant may not be safe for you. Always discuss your medical history with your healthcare provider before starting any new medication.
- Pregnancy: Fulvestrant can harm an unborn baby and is contraindicated during pregnancy due to the risk of fetal harm or birth defects.
- Severe liver disease: Fulvestrant is processed by the liver, and severe liver disease may impair your body’s ability to metabolize the drug, increasing the risk of side effects or toxicity.
- Bleeding disorders or low platelet count: Since Fulvestrant is administered via injection, individuals with bleeding disorders or low platelets may face a higher risk of bleeding complications at the injection site.
- Allergy to Fulvestrant or its components: If you are allergic to Fulvestrant or any of its inactive ingredients, taking this medication could trigger a serious allergic reaction.
Drug to Drug Interactions with Fulvestrant
Certain medications can interact with Fulvestrant, potentially affecting its effectiveness or increasing the risk of side effects. Inform your healthcare provider about all medications you are taking, including prescription drugs, over-the-counter medications, and supplements. Below are some medications that may interact with Fulvestrant:
- Blood thinners (anticoagulants): Medications like warfarin (Coumadin) may increase the risk of bleeding when taken with Fulvestrant.
- Rifampin (Rifadin): This antibiotic can reduce Fulvestrant’s effectiveness by accelerating its breakdown in the body.
- Phenytoin (Dilantin): This anti-seizure medication may also reduce Fulvestrant’s effectiveness by speeding up its metabolism.
- Carbamazepine (Tegretol): Another anti-seizure medication that can lower Fulvestrant levels in the bloodstream, reducing its effectiveness.
Fulvestrant in Pregnancy
Is it safe to take Fulvestrant when pregnant?
No, Fulvestrant is not considered safe during pregnancy. It is classified as a Category D medication, meaning there is evidence of potential harm to the developing fetus. If you are pregnant or planning to become pregnant, it is crucial to avoid taking Fulvestrant. Always use effective contraception while on this medication, and contact your healthcare provider immediately if you suspect you may be pregnant.
Fulvestrant while Breastfeeding
Is it safe to take Fulvestrant while breastfeeding?
No, Fulvestrant is not recommended for use while breastfeeding. Although it is not definitively known whether Fulvestrant passes into breast milk, the potential risk to a nursing infant is significant enough that breastfeeding should be avoided during treatment. If you are breastfeeding, discuss alternative treatment options with your healthcare provider.
Estimated Cost of Fulvestrant
The estimated cost of a 30-day supply of Fulvestrant without insurance ranges from $1,000 to $2,500. However, with a GoodRx coupon, the price may be reduced to approximately $800 to $1,200. Prices can vary depending on your location and pharmacy, so it’s a good idea to check with your local pharmacy for the most accurate pricing.
Possible Alternatives to Fulvestrant
Depending on the specific type of breast cancer you have and your overall health, there may be alternative treatments or lifestyle adjustments available. It’s essential to discuss these options with your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore your options further.
Breast Cancer Treatment Options
Other treatment options for breast cancer include surgery, radiation therapy, chemotherapy, and targeted therapies such as trastuzumab (Herceptin). Additionally, lifestyle changes like maintaining a healthy diet, engaging in regular physical activity, and limiting alcohol consumption may help manage symptoms and improve overall outcomes.
Hormone Receptor-Positive Breast Cancer
For hormone receptor-positive breast cancer, alternative hormone therapies such as tamoxifen or aromatase inhibitors (e.g., anastrozole) may be considered. Your healthcare provider can help determine the most appropriate treatment based on your individual needs.
Metastatic Breast Cancer
Treatment options for metastatic breast cancer may include chemotherapy, immunotherapy, or targeted therapies. Palliative care, which focuses on managing symptoms and improving quality of life, is also an important consideration for many patients.
Estrogen Receptor-Positive Breast Cancer
For estrogen receptor-positive breast cancer, alternatives to Fulvestrant may include aromatase inhibitors or selective estrogen receptor modulators (SERMs) like tamoxifen. Additionally, lifestyle modifications such as reducing dietary fat and increasing physical activity may provide added benefits.
Advanced Breast Cancer
Treatment for advanced breast cancer may involve chemotherapy, radiation, or newer targeted therapies like CDK4/6 inhibitors (e.g., palbociclib). Supportive care and symptom management are also critical components of treatment for advanced stages of the disease.
Locally Advanced Breast Cancer
For locally advanced breast cancer, treatment often includes a combination of surgery, radiation, and chemotherapy. Your healthcare provider can help determine if a multimodal approach is appropriate for your situation.
Recurrent Breast Cancer
Treatment for recurrent breast cancer may involve surgery, radiation, or systemic therapies such as chemotherapy or hormone therapy. In some cases, genetic testing may help guide treatment decisions and identify the most effective options.
Triple-Negative Breast Cancer
For triple-negative breast cancer, chemotherapy is typically the primary treatment. However, newer options like immunotherapy (e.g., pembrolizumab) are being explored, and clinical trials may offer additional opportunities for innovative treatments.
Invasive Breast Cancer
Treatment for invasive breast cancer often includes surgery, radiation, and systemic therapies such as chemotherapy or hormone therapy. Your healthcare provider can help you decide if a combination of treatments is the best approach for your condition.
Non-Invasive Breast Cancer
For non-invasive breast cancer, treatment options may include surgery (such as a lumpectomy or mastectomy) and radiation. Hormone therapy may also be considered for certain types of non-invasive breast cancer.
Recent Updates on Fulvestrant Research
Recent studies on Fulvestrant have focused on its use in combination with other therapies to improve outcomes for patients with advanced or metastatic breast cancer. For instance, research has shown that combining Fulvestrant with CDK4/6 inhibitors like palbociclib (Ibrance) or ribociclib (Kisqali) can significantly extend progression-free survival in patients with hormone receptor-positive, HER2-negative breast cancer. Ongoing clinical trials are also investigating the potential of Fulvestrant in combination with other targeted therapies to further enhance its effectiveness.
As research progresses, new treatment protocols may emerge, offering additional options for patients. If you are interested in learning more about the latest research or clinical trials involving Fulvestrant, speak with your healthcare provider or schedule a telemedicine appointment with one of our providers to discuss whether these options may be suitable for you.
